![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, July 30, 2016 4:40:51 PM
"Norchi has deep contacts in the world of contract manufacturing. Norchi said that Arch had spoken with many candidate contract manufacturers, and wanted one that could do scaled-up liquid phase peptide synthesis on both sides of the Atlantic equally. A contract is in place, and this organization is now making AC5 stocks. Norchi felt it would imprudent to name right now the manufacturer or the cost per unit for manufacture, but assured us that despite the relative expensiveness of making AC5, he is confident a price with considerable profit margin that the market will easily bear without drama or protest can be set. Arch has a consulting advisor who is the author of the leading textbook in biochemistry on methods of peptide synthesis."
Arch Therapeutics Science
http://sciencebehindac5.blogspot.com/
Elevator Summary of Arch http://www.archtherapeutics.blogspot.com/
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM